NCT01892813

Dissemination of a Tailored Tobacco Quitline for Rural Veteran Smokers

Tailored Tobacco Intervention

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 411 (actual)
• Sponsor: Mark Vander Weg · Academic / Other
• Sex: All
• Age: 18 Years – 99 Years
• Healthy volunteers: Accepted

Summary

The project is designed to examine the effectiveness of strategies to increase access to treatment for tobacco use and dependence among rural Veteran smokers. In addition, it will examine whether tailored treatment that is designed to address common comorbid conditions that are related to cigarette smoking enhances success with quitting relative to enhanced standard of care. The investigators hypothesize that participants assigned to the tailored tobacco cessation intervention will report greater cessation rates at six months. The investigators also anticipate more favorable outcomes on measures of depressive symptoms, alcohol use, and body weight.

Conditions

• Nicotine Dependence
• Tobacco Use

Interventions

Type	Name	Description
DRUG	Nicotine replacement therapy - Transdermal nicotine patch	Medication selection will be determined based on individual participant preferences, medical history, and contraindications.
DRUG	Nicotine replacement therapy - Nicotine gum	Medication selection will be determined based on individual participant preferences, medical history, and contraindications.
DRUG	Nicotine replacement therapy - Nicotine lozenge	Medication selection will be determined based on individual participant preferences, medical history, and contraindications.
DRUG	Bupropion	Medication selection will be determined based on individual participant preferences, medical history, and contraindications.
DRUG	Varenicline	Medication selection will be determined based on individual participant preferences, medical history, and contraindications.
DRUG	Combination pharmacotherapy - Transdermal nicotine patch + nicotine gum	Medication selection will be determined based on individual participant preferences, medical history, and contraindications.
DRUG	Combination pharmacotherapy - Transdermal nicotine patch + nicotine lozenge	Medication selection will be determined based on individual participant preferences, medical history, and contraindications.
DRUG	Combination pharmacotherapy - Transdermal nicotine patch + bupropion	Medication selection will be determined based on individual participant preferences, medical history, and contraindications.
BEHAVIORAL	Tobacco quitline referral	Participants assigned to this condition will receive a referral to their state tobacco quitline. The specific behavioral treatment that is provided will differ slightly depending upon the services available through the participant's state of residence.
BEHAVIORAL	Tailored behavioral intervention	Participants will receive a standard six session cognitive behavioral intervention for smoking cessation combined with supplemental treatment modules based on individual need and preference.
BEHAVIORAL	Alcohol use risk reduction	Participants engaging in risky alcohol use may receive this six-session telephone-based behavioral intervention for reducing alcohol use.
BEHAVIORAL	Behavioral activation for depressive symptoms	Participants with elevated depressive symptoms may receive this six-session telephone-based behavioral activation intervention.
BEHAVIORAL	Behavioral management of postcessation weight gain	Participants with concerns about gaining weight after quitting smoking may receive this six-session telephone-based behavioral self-management intervention designed to help attenuate post-cessation weight gain.

Timeline

• Start date: 2013-07-01
• Primary completion: 2018-01-01
• Completion: 2018-01-01
• First posted: 2013-07-04
• Last updated: 2017-07-11

Locations

1 site across 1 country: United States